Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation with Hepatocellular Carcinoma

Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation with Hepatocellular Carcinoma

Tumor recurrence is the main limitation of liver transplantation (LT) in patients with hepatocellular carcinoma (HCC) and can be promoted by immunosuppressants. However, there is no prevention or treatment for HCC recurrence after LT. Here we describe a clinical-scale method for an adoptive immunoth...

Full description

Bibliographic Details
Main Authors: Masahiro Ohira, Seigo Nishida M.D., Ph.D., Panagiotis Tryphonopoulos, Akin Tekin, Gennaro Selvaggi, Jang Moon, David Levi, Camillo Ricordi, Kohei Ishiyama, Yuka Tanaka, Hideki Ohdan, Andreas G. Tzakis
Format: Article
Language:English
Published: SAGE Publishing 2012-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368911X627589

Internet

https://doi.org/10.3727/096368911X627589

Similar Items